Stoneridge, Inc. announced financial results for the fourth quarter and full-year ended December 31, 2024. For Q4 2024, sales were $218.2 million, with an adjusted operating loss of $(4.0) million and adjusted EPS of $(0.18). Full-year 2024 sales reached $908.3 million, with an adjusted operating income of $2.4 million and adjusted EPS of $(0.47).
The company reported significant cash flow improvements, with net cash provided by operating activities increasing by approximately $43 million year-over-year, driven by a $36 million reduction in inventory balances. Free cash flow for 2024 was $23.8 million, an increase of $55.5 million compared to the prior year. Stoneridge also amended its Credit Facility to provide financial covenant relief through the first three quarters of 2025.
For full-year 2025, Stoneridge issued guidance including sales of $860 million to $890 million, adjusted EBITDA of $38 million to $42 million, and free cash flow of $25 million to $30 million. MirrorEye revenue is expected to almost double to $120 million in 2025. The company also established long-term targets, aiming for at least $975 million in revenue and $70 million in EBITDA by 2026, and $1.3 billion to $1.45 billion in revenue with $160 million to $200 million in EBITDA by 2029.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.